Agenda Topics- EV-based Clinical Trials in Various Disease Classes
- EV-based Drug Delivery
- EV-based Therapeutics Development
- EV-Engineering and Modifications for Drug Delivery and Therapeutics
- EVs-derived from Stem Cells with Regenerative Potential
- Exosomes-EVs in Various Disease Classes: Cancer, Cardiovascular Disease, CNS Disease
Sponsorship and Exhibition OpportunitiesJeff Fan, Exhibition Manager jeff@selectbioconferences.com +1-510-857-4865
|
Confirmed Speakers to dateChulhee Choi, Professor and Chair, BioMedical Imaging Center, Korea Advanced Institute of Science and Technology (KAIST), President, ILIAS Biologics Incorporated Randolph Corteling, Head of Research, ReNeuron Ltd. Bernd Giebel, Group Leader, Institute for Transfusion Medicine, University Hospital Duisburg-Essen Mario Gimona, Head of Manufacturing-GMP, CSO of Celericon Therapeutics, Paracelsus Medical University Salzburg Behzad Mahdavi, Vice President of Strategic Innovation & Alliances, Lonza
|